These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6445324)

  • 41. Immunological enhancement of muscle allografts induced by serum from tolerant rats.
    Gutmann E; Hasek M; Chutná J
    Folia Biol (Praha); 1978; 24(1):25-31. PubMed ID: 344077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on enhancement of cardiac and renal allografts in the rat.
    Tilney NL; Bell PR
    Transplantation; 1974 Jul; 18(1):31-7. PubMed ID: 4151911
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanisms of prolongation of graft survival.
    Carpenter CB
    Transplant Proc; 1979 Dec; 11(4):1885-8. PubMed ID: 161100
    [No Abstract]   [Full Text] [Related]  

  • 44. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histocompatibility in organ transplantation.
    Morris PJ
    Ann R Coll Surg Engl; 1973 Dec; 53(6):324-39. PubMed ID: 4585779
    [No Abstract]   [Full Text] [Related]  

  • 46. Rabbit anti rat lymphocyte serum: immunosuppression mediated by IgM antibodies.
    Jakobsen A; Flatmark A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):501-6. PubMed ID: 4566179
    [No Abstract]   [Full Text] [Related]  

  • 47. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism for prolonged survival of pig renal allografts.
    Perper RJ; Bowersox BE; Van Gorder TJ
    Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression of skin allograft rejection by post-transplantation administration of specific anti-lymphocyte serum.
    Sundaresan P; Sainis KB; Phondke GP; Sundaram K
    Immunol Lett; 1986 Apr; 12(4):201-5. PubMed ID: 3522415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions between liver allografts and lymphocytotoxic alloantibodies in inbred rats.
    Houssin D; Bellon B; Brunaud MD; Gugenheim J; Settaf A; Meriggi F; Emond J
    Hepatology; 1986; 6(5):994-8. PubMed ID: 3530951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Further studies on the biological properties of guinea-pig IgG1 antibodies: anti-lymphocyte antibodies.
    Vuagnat P
    Immunology; 1974 Sep; 27(3):351-7. PubMed ID: 4213122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific suppression of renal allograft rejection by treatment with antigen and antibody.
    Stuart FP; Fitch FW; Rowley DA
    Transplant Proc; 1970 Dec; 2(4):483-8. PubMed ID: 4939695
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperacute rejection and enhancement of rabbit-kidney allografts.
    McDowall RA; Batchelor JR; French ME
    Lancet; 1973 Apr; 1(7807):797-801. PubMed ID: 4121222
    [No Abstract]   [Full Text] [Related]  

  • 55. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 56. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

  • 59. Adaptation to human and animal organ allografts: reconsideration of a hypothesis.
    Miller J; Lifton J; DeWolf WC; Hattler BG
    Transplant Proc; 1976 Jun; 8(2):217-24. PubMed ID: 132726
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunologic properties of placental eluates.
    Revillard JP; Brochier J; Robert M; Bonneau M; Traeger J
    Transplant Proc; 1976 Jun; 8(2):275-9. PubMed ID: 820023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.